How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals
Cholesterol Conversations
00:00
Bempedoic Acid: A Promising Non-Statin Option for Cholesterol Treatment
This chapter discusses the outcomes of a trial with Bempedoic acid, highlighting its effectiveness in reducing adverse cardiovascular events, LDL cholesterol, and high sensitive CRP. The speakers emphasize the need to consider non-statin options for cholesterol treatment and discuss the potential of combination therapy with Bempedoic acid and PCSK9 inhibitors.
Transcript
Play full episode
